Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
MLAB - Mesa Laboratories, Inc.
Market Cap 678.69M P/E 741.47 EPS this Y 87.50% Ern Qtrly Grth -
Income -250.31M Forward P/E 76.86 EPS next Y 7.60% 50D Avg Chg -3.00%
Sales 223.71M PEG - EPS past 5Y 7.43% 200D Avg Chg -21.00%
Dividend 1.00% Price/Book 1.72 EPS next 5Y - 52W High Chg -41.00%
Recommedations 2.50 Quick Ratio 1.20 Shares Outstanding 5.41M 52W Low Chg 10.00%
Insider Own 5.72% ROA 1.24% Shares Float 5.27M Beta 0.85
Inst Own 91.86% ROE -92.98% Shares Shorted/Prior 220.85K/180.75K Price 126.05
Gross Margin 63.17% Profit Margin -111.89% Avg. Volume 46,774 Target Price 130.00
Oper. Margin 10.93% Earnings Date Nov 4 Volume 37,370 Change -1.02%
Technology | Scientific & Technical Instruments | United States
About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Mesa Laboratories, Inc. News
09/14/24 Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 30% Discount?
09/04/24 AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
08/26/24 Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock
08/26/24 Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade
08/16/24 Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance
08/05/24 Mesa Labs: Fiscal Q1 Earnings Snapshot
08/05/24 Mesa Labs Announces First Quarter Results
07/31/24 Andvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2
07/29/24 What Does Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Indicate?
07/08/24 MESA LABS DECLARES QUARTERLY DIVIDEND
06/07/24 Mesa Laboratories Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
06/05/24 Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
05/31/24 Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
05/22/24 Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
04/18/24 The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable
04/08/24 MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
04/08/24 Best Value Stocks to Buy for April 8th
04/01/24 Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
03/15/24 Mesa Labs Releases Second Annual Responsible Business Program Brochure
03/08/24 Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate
MLAB Chatroom

User Image insiderbuyingselling Posted - 5 days ago

$MLAB new insider selling: 1499 shares. http://insiderbuyingselling.com/?t=MLAB

User Image IN0V8 Posted - 1 month ago

$MLAB Opportunity Evercore ISI raises target price to $120 from $106

User Image BangaloreBidder Posted - 1 month ago

$UHG, $COHN, $AXL, $MLAB: Retail Extremely Bullish On These 4 Stocks Amid Market Rout https://stocktwits.com/news/markets/equity/uhg-cohn-axl-mlab-retail-extremely-bullish/c7H86o4RRa

User Image DonCorleone77 Posted - 1 month ago

$MLAB Mesa Labs reports Q1 EPS 62c, consensus 44c Reports Q1 revenue $58.17M, consensus $55.74M. "We had a successful start our first quarter of the fiscal year by delivering positive momentum for revenues, orders, profitability, and debt levels while also demonstrating continued strategic traction. Sales and marketing improvements resulted in 3.0% core organic growth in the quarter, with orders also improved as we built backlog in the quarter. Our process improvement and productivity initiatives bore fruit with strong increases in both gross profit percentage and AOI margin percentage when excluding unusual items. From a balance sheet perspective, we repaid $9.4 million in debt during the quarter which reduced our total Net Leverage Ratio* to 3.41. We remain committed to drive this ratio down below 3.0x" said Gary Owens, Chief Executive Officer of Mesa.

User Image epsguid Posted - 1 month ago

$MLAB reported earnings of $2.29, consensus was $1.74 via @eWhispers #epsbeat http://eps.sh/d/mlab

User Image Stock_Titan Posted - 1 month ago

$MLAB Mesa Labs Announces First Quarter Results https://www.stocktitan.net/news/MLAB/mesa-labs-announces-first-quarter-n74zes9s20ii.html

User Image NVDAMillionaire Posted - 07/30/24

$MLAB Mesa Laboratories, Inc. (NASDAQ:MLAB): A Diversified Life Sciences Leader Navigating Macroeconomic Headwinds http://beyondspx.com/2024/07/30/mesa-laboratories-inc-nasdaqmlab-a-diversified-life-sciences-leader-navigating-macroeconomic-headwinds/

User Image DesiMiami Posted - 2 months ago

$MLAB another 10 % today boom 💥

User Image DesiMiami Posted - 2 months ago

$MLAB well up 11.55 % today. Institutional buyers past 21 days … moving up in silence when no one is watching 👀

User Image Fullratio Posted - 2 months ago

$MLAB equity has dropped by 64% since the previous quarter and by 63% year-on-year: https://fullratio.com/stocks/nasdaq-mlab/mesa-laboratories

User Image Fullratio Posted - 06/30/24

$MLAB debt to equity has soared by 162% QoQ: https://fullratio.com/stocks/nasdaq-mlab/mesa-laboratories

User Image DesiMiami Posted - 06/25/24

$MLAB what happened here ? down so much . No stock movement but down .No news no Pr .No volume.On the charts it shows in the past constant recovery around 89’s. Can’t find any info on it …

User Image epsguid Posted - 3 months ago

$MLAB reported earnings of $2.25 via @eWhispers http://eps.sh/d/mlab

User Image DonCorleone77 Posted - 3 months ago

$MLAB Mesa Labs reports Q4 non-GAAP EPS $2.77 vs. $2.20 last year Reports Q4 revenue $58.90M vs.$55.95M last year. "Several significant strategic milestones were attained in 4Q24 including: closing the acquisition of the GKE China entity on December 31, 2023; extending and expanding our bank credit facility to $200,000 which enabled us to repurchase $75,000, or 43%, of our outstanding 2025 Convertible Notes and ensure that we have the cash available to complete the full repurchase at maturity, if not sooner; executing a restructuring in our Clinical Genomics division to better align our cost structure with the current revenue headwinds; and reducing inventory, excluding the impact of GKE, by 19.4% versus FY23 via our improved procurement processes and the normalization of supply chain delivery times," said Gary Owens, CEO.

User Image Stock_Titan Posted - 3 months ago

$MLAB Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results https://www.stocktitan.net/news/MLAB/mesa-labs-announces-fourth-quarter-and-full-fiscal-year-2024-kqlr5e7szrrm.html

User Image TheDizPlinTrader Posted - 3 months ago

$MLAB Key Levels: 1-Hour Support & Resistance 🚀 Current Price: $95.70 🔹 Support Level: $90.91 Zone: This area has historically provided strong support, often acting as a buffer where buyers step in to prevent further declines. Monitoring this level can offer insights into potential rebounds. 🔸 Resistance Level: $100.49 Zone: This level has acted as significant resistance, where selling pressure tends to emerge, halting price advances. Watching reactions at this level can indicate potential breakouts or rejections. News: Mesa Laboratories announced the acquisition of a new technology company. 🔍 Join our exclusive Discord community for in-depth analysis, real-time updates, expert insights, and live precise entry and exit updates. Unlock precise trading levels, strategies, and tips to take your trading to the next level. Visit my profile for the website link and more details. Let's trade smarter together!

User Image DesiMiami Posted - 05/31/24

$MLAB this was a drop . Based on what ? Second rescheduled earnings ? Or any other reason

User Image HaltTradeAlert Posted - 05/31/24

$MLAB Halt Time: 09:32:13 Issue Symbol: MLAB Reason Code: LUDP Last Price: $104.86 Market Cap: $565620086 Volume: 6013.0 Relative Volume: 0.2 Shares Float: 5394050 Our members get this alert real time and sent to their phone just like a text. Members also get free real time news catalyst alerts! Go to our website and join our community for free! www.HaltTradeAlert.com

User Image TradesViz Posted - 05/31/24

🤗 Calm? 🤪 Excited? 🥱 Tired? Tag it in your day explore page with day plans on TradesViz! Events today: Core PCE Price Index, Personal income/spending numbers 🏛️ Earnings: $DOOO $MLAB and more! Last day of the month! Make sure to spend some time summarizing your data! https://t.co/OQyAKkTUaM #tradingjournal #trading #stockmarket

User Image OpenOutcrier Posted - 05/31/24

$MLAB (+5.0% pre) Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results - SI https://ooc.bz/l/34334

User Image TheDizPlinTrader Posted - 05/31/24

$MLAB Key Levels: 1-Hour Support & Resistance 🚀 Current Price: $113.74 🔹 Support Level: $108.05 Zone: This area has historically provided strong support, often acting as a buffer where buyers step in to prevent further declines. Monitoring this level can offer insights into potential rebounds. 🔸 Resistance Level: $119.43 Zone: This level has acted as significant resistance, where selling pressure tends to emerge, halting price advances. Watching reactions at this level can indicate potential breakouts or rejections. News: Mesa Laboratories announced the acquisition of a new technology company. Earnings Estimate: Estimated EPS: 1.34 🔍 Join our exclusive Discord community for in-depth analysis, real-time updates, expert insights, and live precise entry and exit updates. Unlock precise trading levels, strategies, and tips to take your trading to the next level. Visit my profile for the website link and more details. Let's trade smarter together!

User Image Stock_Titan Posted - 05/31/24

$MLAB Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results https://www.stocktitan.net/news/MLAB/mesa-laboratories-inc-revises-earnings-announcement-date-for-org8ed8629a6.html

User Image Stock_Titan Posted - 05/22/24

$MLAB Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024 https://www.stocktitan.net/news/MLAB/mesa-laboratories-inc-revises-earnings-announcement-date-for-vb4p4wfsyktx.html

User Image StockInvest_us Posted - 4 months ago

Signal alert: $MLAB - Overbought Trend Short (Overvalued) https://stockinvest.us/l/z3u1LclMEU

User Image StockInvest_us Posted - 4 months ago

Signal alert: $MLAB - Overbought Trend Short (Overvalued) https://stockinvest.us/l/Y7FAEsmp9s

User Image Stock_Titan Posted - 5 months ago

$MLAB MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES https://www.stocktitan.net/news/MLAB/mesa-labs-announces-amendment-to-credit-facility-and-repurchase-of-d1648qu30xg3.html

User Image Stock_Titan Posted - 5 months ago

$MLAB Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024 https://www.stocktitan.net/news/MLAB/mesa-laboratories-inc-to-announce-unaudited-fourth-quarter-and-full-vyg9lxm51of3.html

User Image TickerDD_com Posted - 6 months ago

From 3/6/2024, looking back across 22 Month-Ends for MLAB, Percentage Change of Average Monthly Price had More Negatives (64%) while Percentage Change of Average Monthly Volume had More Positives (91%) $MLAB #MLAB #MLABStock #TickerDD https://www.youtube.com/watch?v=UzmdQg7Fnmw

User Image Laynester Posted - 6 months ago

$IDXX $ZTS $MLAB $APPL We love short shorts - on our short list today. We are profiting on all as of 3/15/2024 8:58am EST. Set a 7% trlr buy; if the long term weekly chart shows a change in price direction (e.g. $AAPL) set a 3.5% trlr buy and let it ride out or wait for a further direction down and reset 7% - 3.5% routine outlined above. You got this!

User Image Stock_Titan Posted - 6 months ago

$MLAB Mesa Labs Releases Second Annual Responsible Business Program Brochure https://www.stocktitan.net/news/MLAB/mesa-labs-releases-second-annual-responsible-business-program-zfidnvio29hi.html

Analyst Ratings
Wells Fargo Underweight Aug 27, 24
Evercore ISI Group Outperform Aug 6, 24
Evercore ISI Group Outperform Jul 2, 24
Evercore ISI Group Outperform Apr 4, 24
Evercore ISI Group Outperform Jan 4, 24
Evercore ISI Group In-Line Jan 4, 21
Keybanc Sector Weight Nov 10, 20
JP Morgan Neutral Oct 2, 20
Jefferies Buy Dec 4, 19
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Archbold Brian David SVP Operations SVP Operations Dec 15 Sell 112.36 1,500 168,540 558 12/19/23
Sakys John CFO CFO Mar 09 Sell 169.97 400 67,988 9,696 03/09/23
Sakys John CFO CFO Mar 09 Option 70.56 400 28,224 10,096 03/09/23
Sakys John CFO CFO Feb 09 Sell 184.27 1,000 184,270 9,696 02/09/23
Sakys John CFO CFO Feb 09 Option 51.85 1,000 51,850 10,696 02/09/23
Sakys John CFO CFO Jan 23 Sell 210.19 2,100 441,399 9,696 01/25/23
Sakys John CFO CFO Jan 23 Option 70.56 2,100 148,176 11,796 01/25/23
Schmieder John Bradley Director Director Jan 13 Sell 191.31 1,571 300,548 68,976 01/17/23
Hall Shannon Director Director Dec 08 Sell 174.975 230 40,244 957 12/09/22
Schmieder John Bradley Director Director Nov 11 Sell 175.45 2,500 438,625 68,976 11/21/22
GUILLEMIN EVAN Director Director Aug 18 Option 111.87 2,680 299,812 32,468 08/19/22
GUILLEMIN EVAN Director Director Aug 18 Sell 196.12 3,692 724,075 28,776 08/19/22
Sakys John CFO CFO Aug 15 Option 70.56 2,000 141,120 10,678 08/17/22
Sakys John CFO CFO Aug 15 Sell 200.56 2,000 401,120 8,678 08/17/22
Tripeny R Tony Director Director Aug 09 Buy 200 500 100,000 500 08/09/22
Owens Gary M President and CEO President and CEO Jun 17 Option 0 1,685 20,081 06/22/22
Owens Gary M President and CEO President and CEO Jun 17 Sell 188.22 1,756 330,514 21,640 06/22/22
Archbold Brian David SVP Operations SVP Operations Jun 17 Option 0 338 492 06/22/22
Archbold Brian David SVP Operations SVP Operations Jun 17 Sell 188.22 392 73,782 813 06/22/22
DINOIA GREGORY SVP Commercial SVP Commercial Jun 17 Option 0 391 3,084 06/22/22
DINOIA GREGORY SVP Commercial SVP Commercial Jun 17 Sell 188.22 555 104,462 3,634 06/22/22
Sakys John CFO CFO Jun 17 Option 0 392 7,906 06/22/22
Sakys John CFO CFO Jun 17 Sell 188.22 722 135,895 8,678 06/22/22
Sullivan John James Director Director Jun 07 Option 70.56 6,193 436,978 24,858 06/13/22
Sullivan John James Director Director Jun 07 Sell 207.76 5,192 1,078,690 23,857 06/13/22
Sakys John CFO CFO Apr 20 Option 51.85 72 3,733 7,586 04/22/22
Sakys John CFO CFO Apr 20 Sell 250.44 72 18,032 7,514 04/22/22
Sakys John CFO CFO Mar 23 Option 51.85 1,600 82,960 9,114 03/25/22
Sakys John CFO CFO Mar 23 Sell 251.22 1,600 401,952 7,514 03/25/22
Sullivan John James Director Director Feb 17 Option 70.56 1,000 70,560 23,857 02/22/22
Sullivan John James Director Director Feb 15 Option 84.17 5,192 437,011 28,049 02/16/22
Sullivan John James Director Director Feb 15 Sell 259.42 5,192 1,346,909 22,857 02/16/22
Sakys John CFO CFO Dec 10 Option 93.74 1,758 164,795 9,272 12/10/21
Sakys John CFO CFO Dec 10 Sell 324.74 1,758 570,893 7,514 12/10/21